Xiang-Lei Yang/nfcr.org
Mar 13, 2025, 05:43
SerRS as a tumor suppressor in breast cancer – NFCR
National Foundation for Cancer Research (NFCR) posted on LinkedIn:
“New research alert! NFCR-supported scientist Dr. Xiang-Lei Yang has discovered that a protein called SerRS—traditionally known for helping build proteins—also acts as a tumor suppressor in breast cancer by blocking the Wnt signaling pathway. Her findings show SerRS can inhibit cancer metastasis, making it a powerful new target for future therapies. A major step forward in the fight against breast cancer!
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53
Apr 19, 2025, 17:17